GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fukuda Denshi Co Ltd (TSE:6960) » Definitions » Capex-to-Revenue

Fukuda Denshi Co (TSE:6960) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 1982. Start your Free Trial

What is Fukuda Denshi Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Fukuda Denshi Co's Capital Expenditure for the three months ended in Dec. 2023 was 円0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was 円32,717.00 Mil.

Hence, Fukuda Denshi Co's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.00.


Fukuda Denshi Co Capex-to-Revenue Historical Data

The historical data trend for Fukuda Denshi Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fukuda Denshi Co Capex-to-Revenue Chart

Fukuda Denshi Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.08 0.11 0.09 0.10

Fukuda Denshi Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Fukuda Denshi Co's Capex-to-Revenue

For the Medical Devices subindustry, Fukuda Denshi Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fukuda Denshi Co's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Fukuda Denshi Co's Capex-to-Revenue falls into.



Fukuda Denshi Co Capex-to-Revenue Calculation

Fukuda Denshi Co's Capex-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-14123) / 140323
=0.10

Fukuda Denshi Co's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 32717
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fukuda Denshi Co  (TSE:6960) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Fukuda Denshi Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fukuda Denshi Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fukuda Denshi Co (TSE:6960) Business Description

Traded in Other Exchanges
N/A
Address
39-4, Hongo 3-chome, Bunkyo-ku, Tokyo, JPN, 113-8483
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.

Fukuda Denshi Co (TSE:6960) Headlines

No Headlines